Clinical Trials Browser

INDUSTRY × Melanoma × tesetaxel × Clear all

NCT01092585 2011-11-08

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Phase 2 Unknown

Melanoma